Atricure Inc. buy Needham & Company LLC
Start price
29.11.23
/
50%
€59.50
Target price
29.11.24
€44.64
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 29.11.24. The prediction end date can be changed by Needham___Company_LL at any time.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Atricure Inc. | - | - |
| iShares Core DAX® | 2.594% | -1.158% |
| iShares Nasdaq 100 | 3.553% | -1.727% |
| iShares Nikkei 225® | 0.687% | -8.354% |
| iShares S&P 500 | 2.209% | -0.942% |
Comments by Needham___Company_LL for this prediction
In the thread Atricure Inc. diskutieren
AtriCure, Inc. (NASDAQ: ATRC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $49.00 price target on the stock.
Ratings data for ATRC provided by MarketBeat